First Citizens Bank & Trust CO Arrowhead Pharmaceuticals, Inc. Transaction History

First Citizens Bank & Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 11, 2022	SELL	$58.09 - $82.51 $239,563 - $340,271	-4,124 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$58.38 - $84.96 $6,538 - $9,515	112 Added 2.79%	4,124 $257,000
Q2 2021 Jul 14, 2021	SELL	$62.15 - $90.32 $51,708 - $75,146	-832 Reduced 17.18%	4,012 $332,000
Q1 2021 Apr 14, 2021	BUY	$61.35 - $90.47 $297,179 - $438,236	4,844 New	4,844 $321,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on First Citizens Bank & Trust CO with notifications on news.